Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid  (GABA) in mice with audiogenic seizures.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism; D000161:Acoustic Stimulation; D000445:Aldehyde Oxidoreductases / Q000378:metabolism; D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D004791:Enzyme Inhibitors; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D012640:Seizures / Q000378:metabolism*; D014631:Valerates / Q000494:pharmacology*; D014635:Valproic Acid / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000613:Aminobutyrates; D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D004983:Ethanolamines; D014631:Valerates; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D000445:Aldehyde Oxidoreductases; D000612:4-Aminobutyrate Transaminase